SCHEMBL3579012

SCHEMBL3579012

CS(=O)(=O)NN(CCc1cccc(C(F)(F)F)c1)C(=O)c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPM8 Q7Z2W7 1/20 0.47
MEN1 O00255 5/20 0.44
KMT2A Q03164 5/20 0.44
LMNA P02545 2/20 0.44
RAB9A P51151 1/20 0.44
NR3C1 P04150 1/20 0.44
MAPT P10636 1/20 0.44
KDM4E B2RXH2 3/20 0.43
PPARG P37231 1/20 0.43
USP2 O75604 2/20 0.43
CYP3A4 P08684 2/20 0.43
NR1I2 O75469 1/20 0.43
ADRB1 P08588 1/20 0.43
HTR1A P08908 1/20 0.43
ADRA2A P08913 1/20 0.43
ADORA3 P0DMS8 1/20 0.43
ADRA2B P18089 1/20 0.43
ADRA2C P18825 1/20 0.43
CHRM3 P20309 1/20 0.43
SLC6A2 P23975 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3232453 0.77 TRPM8 (0.53) TRPM8MEN1KMT2ALMNAMAPT
SCHEMBL8087708 0.76 TRPM8 (0.45) TRPM8MEN1KMT2ALMNARAB9A
SCHEMBL3237258 0.73 TRPM8 (0.51) TRPM8MEN1KMT2ALMNAMAPT
SCHEMBL8090727 0.70 TRPM8 (0.51) TRPM8MEN1KMT2ALMNARAB9A
SCHEMBL28423545 0.70 FFAR4 (0.53) TRPM8MEN1KMT2ALMNARAB9A
SCHEMBL3233030 0.70 NAMPT (0.64) MEN1KMT2ARAB9ACYP3A4CYP1A2
SCHEMBL27687323 0.69 TAAR1 (0.51) MEN1KMT2AMAPTKDM4EHTR2A
SCHEMBL5725106 0.68 POLB (0.60) MEN1KMT2ANR3C1MAPTKDM4E
SCHEMBL169714 0.68 TAAR1 (0.61) MEN1KMT2ALMNAMAPTHTR1A
SCHEMBL10312254 0.67 CYP19A1 (0.57) MEN1KMT2ALMNARAB9ANR3C1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7678818-B2 Anthranilamide and 2-amino-heteroarene-carboxamide compounds HOFFMANN-LA ROCHE INC. (US) 2010-03-16 US disclosed
US-20070219261-A1 Anthranilamide and 2-amino-heteroarene-carboxamide compounds HOFFMANN-LA ROCHE INC. 2007-09-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070219261-A1 Anthranilamide and 2-amino-heteroarene-carboxamide compounds AADAT, AAAS, AADAC TRPM8 1917/4885MEN1 1293/4885KMT2A 341/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.